2,2′,4,4′-Tetrahydroxybenzophenone | CAS:131-55-5

We serve 2,2′,4,4′-Tetrahydroxybenzophenone CAS:131-55-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,2',4,4'-Tetrahydroxybenzophenone

Product Name: 2,2',4,4'-Tetrahydroxybenzophenone
Other Name: Bis(2,4-dihydroxyphenyl)methanone
CAS No: 131-55-5
MF: C13H10O5
MW: 246.21500
Density: 1.526 g/cm3
Boiling point: 531.2ºC at 760 mmHg
Melting point: 198-200 °C(lit.)
Flash point: 289.2ºC
Refractive index: 1.718
UN Number: UN3272
UN Proper Shipping Name: ESTERS, N.O.S.
Transport hazard class: 3
Packing group: III
 
Specification
Appearance: Light yellow green crystalline powder
Assay: ≥99%
Loss on drying: ≤0.50%
Heavy metal: ≤5ppm
Hazen: ≤3.0
Turbidity: ≤12 NTU
 
Application
Widely used in polyester, paints and cosmetics, etc. 
In recent years, the application on fabrics has been paid more and more attention by the textile industry.
FDA approved Class I sunscreen.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 2,2′,4,4′-Tetrahydroxybenzophenone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Bis(2,4-dihydroxyphenyl)methanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Bis(2,4-dihydroxyphenyl)methanone Use and application,Bis(2,4-dihydroxyphenyl)methanone technical grade,usp/ep/jp grade.


Related News: With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near4-isothiocyanatobenzonitrile manufacturer This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?2-(Methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylic acid tert-butyl ester supplier This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?p-Anisaldehyde vendor Hong Kong confirmed its 14th coronavirus case late Saturday. The patient, an 80-year-old man, had traveled for a few hours to mainland China in early January, and later spent several days on a cruise ship in Japan with more than 3,000 passengers and employees.Remogliflozin is economical than other similar agents currently available in sodium glucose co-transporter-2 (SGLT2) inhibitors class, which shall help for its better access among middle and low socio-economic strata of the society, he added.